BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16328685)

  • 1. Use of semiflexible applicators for radiofrequency ablation of liver tumors.
    Gaffke G; Gebauer B; Knollmann FD; Helmberger T; Ricke J; Oettle H; Felix R; Stroszczynski C
    Cardiovasc Intervent Radiol; 2006; 29(2):270-5. PubMed ID: 16328685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR-guided radiofrequency ablation of hepatic malignancies at 1.5 T: initial results.
    Mahnken AH; Buecker A; Spuentrup E; Krombach GA; Henzler D; Günther RW; Tacke J
    J Magn Reson Imaging; 2004 Mar; 19(3):342-8. PubMed ID: 14994303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MRI-guided percutaneous radiofrequency ablation of hepatic neoplasms--first technical and clinical experiences].
    Huppert PE; Trübenbach J; Schick F; Pereira P; König C; Claussen CD
    Rofo; 2000 Aug; 172(8):692-700. PubMed ID: 11013611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential advantages of the MRI for the radiofrequency ablation of liver tumors].
    Gaffke G; Gebauer B; Gnauck M; Knollmann FD; Helmberger T; Ricke J; Oettle H; Felix R; Stroszczynski C
    Rofo; 2005 Jan; 177(1):77-83. PubMed ID: 15657824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results].
    Boss A; Clasen S; Kuczyk M; Anastasiadis A; Schmidt D; Claussen CD; Schick F; Pereira PL
    Rofo; 2005 Aug; 177(8):1139-45. PubMed ID: 16021547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiofrequency ablation therapy combined with suture and ligation surgery for patients with giant cavernous hemangiomas of the liver].
    Fan RF; Chai FL; He GX; Wan WX; Bai MD; Cao ML; Li HM; Yan SZ
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(30):2134-7. PubMed ID: 17064621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR-guided radiofrequency ablation in a 0.2-T open MR system: technical success and technique effectiveness in 100 liver tumors.
    Clasen S; Boss A; Schmidt D; Schraml C; Fritz J; Schick F; Claussen CD; Pereira PL
    J Magn Reson Imaging; 2007 Oct; 26(4):1043-52. PubMed ID: 17896364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
    Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR-guided interstitial laser thermotherapy of colorectal liver metastases: efficiency, safety and patient survival.
    Pech M; Wieners G; Freund T; Dudeck O; Fischbach F; Ricke J; Seemann MD
    Eur J Med Res; 2007 Apr; 12(4):161-8. PubMed ID: 17509960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision.
    Burak WE; Agnese DM; Povoski SP; Yanssens TL; Bloom KJ; Wakely PE; Spigos DG
    Cancer; 2003 Oct; 98(7):1369-76. PubMed ID: 14508822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation.
    Svatek RS; Sims R; Anderson JK; Abdel-Aziz K; Cadeddu JA
    Urology; 2006 Mar; 67(3):508-12. PubMed ID: 16504265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance-guided freehand radiofrequency ablation of malignant liver lesions: a new simplified and time-efficient approach using an interactive open magnetic resonance scan platform and hepatocyte-specific contrast agent.
    Fischbach F; Lohfink K; Gaffke G; Wybranski C; Mohnike K; Wonneberger U; Pech M; Jungnickel K; Ricke J; Strach K
    Invest Radiol; 2013 Jun; 48(6):422-8. PubMed ID: 23399808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of necrosis after laser-induced thermotherapy in contrast-enhanced MRI and implications for treatment success].
    Kühn JP; Puls R; Wallaschowski H; Heidecke CD; Rosenberg C; Hosten N
    Rofo; 2008 Sep; 180(9):816-20. PubMed ID: 18671194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-related changes of radiofrequency ablation lesion in the normal rabbit liver: findings of magnetic resonance imaging and histopathology.
    Tsuda M; Rikimaru H; Majima K; Yamada T; Saito H; Ishibashi T; Takahashi S; Miyachi H; Endoh M; Yamada S
    Invest Radiol; 2003 Aug; 38(8):525-31. PubMed ID: 12874519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of radiofrequency ablation therapy in patients with hepatic cavernous hemangiomas].
    Fan RF; Chai FL; He GX; Li RZ; Wan WX; Bai MD; Zhu WK; Cao ML; Li HM; Yan SZ
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1608-12. PubMed ID: 16185527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
    Amersi FF; McElrath-Garza A; Ahmad A; Zogakis T; Allegra DP; Krasne R; Bilchik AJ
    Arch Surg; 2006 Jun; 141(6):581-7; discussion 587-8. PubMed ID: 16785359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous radiofrequency ablation of pulmonary tumors--is there a difference between treatment under general anaesthesia and under conscious sedation?
    Hoffmann RT; Jakobs TF; Lubienski A; Schrader A; Trumm C; Reiser MF; Helmberger TK
    Eur J Radiol; 2006 Aug; 59(2):168-74. PubMed ID: 16730424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.